Trials / Conditions / Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder
Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder
3 registered clinical trials studyying Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B NCT06723457 | Northwestern University | Phase 2 |
| Recruiting | Epcoritamab for the Treatment of Relapsed or Refractory Post Transplant Lymphoproliferative Disorders NCT06672705 | Timothy Voorhees | Phase 1 |
| Completed | Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positi NCT02900976 | Children's Oncology Group | Phase 2 |